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Abstract 
Picrotoxin, an antagonist of structurally-rated GABAA receptors (GABAARs) and glycine receptors 
(GlyRs), is an equimolar mixture of picrotoxinin (PTXININ) and picrotin (PTN). These compounds 
share a common structure except that PTN contains a slightly larger dimethylmethanol in place of the 
PTXININ isopropenyl group. Although the homomeric α1 GlyR is equally sensitive to both compounds, 
we show here that homomeric α2 and α3 GlyRs, like most GABAARs, are selectively inhibited by 
PTXININ. As conservative mutations to pore-lining 6’ threonines equally affect the sensitivity of the α1 
GlyR to both compounds, we conclude that PTXININ and PTN bind to 6’ threonines by hydrogen 
bonding with exocyclic oxygens common to both molecules. In contrast, substitution of the 2’ pore-
lining glycine by serine selectively reduces PTN sensitivity, whereas the introduction of 2’ alanines 
selectively increases PTXININ sensitivity. These results define the orientation of PTXININ and PTN 
binding in the α1 GlyR pore and allow us to conclude that the relatively reduced sensitivity of PTN at 
GABAARs and α2 and α3 GlyRs is due predominantly to its larger size and reduced ability to form 
hydrophobic interactions with 2’ alanines.  
 
Keywords: ligand-gated ion channel; cys-loop receptor; site-directed mutagenesis; binding site; 
molecular structure and function; chloride channel 
Running title: Glycine receptor picrotoxin binding site 
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Glycine receptor (GlyR) and GABAA receptor (GABAAR) chloride channels mediate inhibitory 
neurotransmission in the central nervous system. Both are members of the pentameric cys-loop receptor 
family that includes the nicotinic acetylcholine receptor (nAChR) as its most studied member (Unwin 
2005). The plant alkaloid convulsant, picrotoxin (PTX), potently inhibits both the GlyR and GABAAR. 
As PTX preferentially inhibits GABAARs in vivo, it is often used for selectively inhibiting GABAergic 
synaptic currents. PTX also inhibits α homomeric GlyRs with a relatively high potency, although αβ 
heteromeric GlyRs are PTX-resistant (Pribilla et al. 1992). Using chimeras of α1 and β GlyR subunits, 
Pribilla and colleagues delimited the PTX sensitive region to the second membrane-spanning (M2) 
domain (Pribilla et al. 1992)  The channel-lining 2’ and 6’ residues of the GlyR and GABAAR were 
subsequently identified as specific determinants of PTX sensitivity (Ffrench-Constant et al. 1993; Zhang 
et al. 1994; Gurley et al. 1995; Wang et al. 1995; Xu and Akabas 1996; Shan et al. 2001). It thus became 
widely hypothesised that PTX binds in the pore. However, a simple pore-blocking mode of action was 
not simple to reconcile with several observations. First, PTX did not behave as a classical GlyR pore-
blocker: its inhibitory potency decreased as glycine concentration increased, and it displayed no use-
dependence (Lynch et al. 1995). Moreover, several lines of evidence suggested that PTX inhibition was 
mediated by an allosteric inhibitory mechanism rather than by direct channel block (Newland and Cull-
Candy 1992; Lynch et al. 1995; Chang and Weiss 2002; Dibas et al. 2002; Hawthorne and Lynch 2005; 
Wang et al. 2006). Nevertheless, recent evidence has strengthened the case for PTX binding in the pore. 
Perhaps the strongest evidence the observation that PTX is trapped in the closed state in both the α1R19’C 
GlyR (Hawthorne and Lynch 2005) and the α2 GlyR (Wang et al. 2006). In addition, molecular docking 
studies on homomeric α1 GlyRs, ρ1 GABAARs and β3 GABAARs have produced a consensus model for 
PTX coordination by the 2’ and 6’ pore-lining residues (Zhorov and Bregestovski 2000; Chen et al. 
2006). However, this model is yet to be experimentally verified. 
PTX is an equimolar mixture of picrotoxinin (PTXININ) and picrotin (PTN). Although the 
structures of these compounds differ only by a single water group (Fig. 1), PTXININ is much more 
potent more than PTN at inhibiting GABAARs (Jarboe et al. 1968). On the other hand, both compounds 
are equally potent inhibitors of α1 GlyRs (Lynch et al. 1995). Our aim is to investigate the effects of 
conservative mutations to 2’ and 6’ residues on GlyR sensitivity to PTXININ and PTN in an attempt to 
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understand their binding mechanisms. We show here that conservative 2’ mutations induce the GlyR to 
discriminate strongly between these compounds, whereas 6’ mutations have similar effects on receptor 
sensitivity to both compounds. This provides strong evidence that the isopropenyl group unique to 
PTXININ interacts closely with the 2’ GlyR side chain, and allows us to infer how GABAARs 
differentiate between PTXININ and PTN. We also investigated whether these compounds may be useful 
as probes for pharmacologically discriminating between currents mediated by α1β and α3β GlyRs at 
inhibitory synapses on pain sensory neurons. 
 
Materials and Methods 
 
Mutagenesis and expression of GlyR cDNAs 
The human GlyR α1 subunit cDNA was subcloned into the pCIS2 plasmid vector. The human 
α2 subunit, which was kindly provided by Dr Paul Groot-Kormelink (University College, London, UK), 
was subcloned into the pcDNA3.1 plasmid vector (Invitrogen). The rat α3 subunit was also subcloned 
into the pcDNA3.1 plasmid vector. The human β subunit was subcloned into the pIRES2-EGFP plasmid 
vector (Clontech, Palo Alto, CA, USA). Site-directed mutagenesis was performed using the 
QuickChange mutagenesis kit (Stratagene, La Jolla, CA, USA) and the successful incorporation of 
mutations was confirmed by sequencing the clones. The only exception was the α1G2’S mutant GlyR, 
which was kindly provided by Dr. Malcolm Slaughter (University of Buffalo, NY, USA). HEK293 cells, 
cultured in Dulbecco’s Modified Eagles Medium, were transfected using a calcium phosphate 
precipitation protocol. When co-transfecting the GlyR α and β subunits, their respective cDNAs were 
combined in a ratio of 1:20. After exposure to transfection solution for 24 hrs, cells were washed twice in 
calcium-free phosphate buffered saline and used for recording over the following 24 - 72 hrs. 
 
Electrophysiology 
Cells were visualised using an inverted fluorescent microscope and currents were measured by 
whole cell patch-clamp recording. Cells were perfused by a control solution that contained (in mM): 140 
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, with the pH adjusted to 7.4 with NaOH. Patch 
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pipettes were fabricated from borosilicate hematocrit tubing (Vitrex, Modulohm, Denmark) and heat 
polished. Pipettes had a tip resistance of 1 - 2 MΩ when filled with the standard pipette solution which 
contained (in mM): 145 CsCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 EGTA, with the pH adjusted to 7.4 with 
NaOH. After establishment of the whole cell configuration, cells were voltage-clamped at –40 mV 
(unless otherwise indicated) and membrane currents were recorded using an Axopatch 1D amplifier and 
pCLAMP9 software (Axon Instruments, Union City, CA, USA). The cells were perfused by a parallel 
array of microtubular barrels through which solutions were gravity-induced. All experiments were 
conducted at room temperature (19 – 22 oC).  
Because α homomers can form functional GlyRs, it is necessary to confirm the incorporation of β 
subunits into functional αβ heteromers. As the GlyR β subunit cDNA was cloned into the pIRES2-EGFP 
plasmid vector, we used GFP fluorescence to identify cells expressing the GlyR β subunit. The 
successful incorporation of β subunits into functional heteromeric GlyRs was inferred by characteristic 
changes in sensitivity to PTXININ and PTN as described below. PTXININ and PTN were obtained from 
Sigma (St Louis, MO, USA) and were stored frozen as a 100 mM stocks in dimethylsulfoxide.  
 
Data Analysis 
Results are expressed as mean ± standard error of the mean of 3 or more independent 
experiments. The Hill equation was used to calculate the saturating current magnitude (Imax), half-
maximal concentration (EC50) and Hill coefficient (nH) values for glycine activation. A similar equation 
was also used to calculate the half maximal concentrations for inhibition (IC50) and nH values of the 
antagonists tested in this study. All curves were fitted using a non-linear least squares algorithm 
(Sigmaplot 9.0, Jandel Scientific, San Rafael, CA, USA). Statistical significance was determined by 
paired or unpaired Student’s t-test, as appropriate, with P < 0.05 representing significance. 
 
Molecular modelling 
A pentameric model of the region from -2’ to 19’ of M2 of the GlyR α1 subunit was built as 
described previously (Hawthorne et al. 2006), by homology with the equivalent region of the nAChR α 
subunit in the electron microscopy-derived closed-channel structure, (pdb code 1OED) (Miyazawa et al. 
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2003). AutoDock 3.0 (Morris and Olsen 1998) was used to explore the possible interactions of PTXININ 
and PTN with the central pore region of the model. The Lamarckian genetic algorithm was used to 
produce 100 docked conformations of each ligand, grouped in clusters within a root-mean-squared 
deviation (rmsd) of 1.5 Å.  
 
Results 
 
Glycine sensitivity 
This study investigated a range of wild type and mutated α homomeric and αβ heteromeric 
GlyRs. Fig. 2A shows examples of whole cell currents activated by different glycine concentrations from 
cells expressing the indicated wild type and mutated GlyRs. Fig. 2B plots the averaged dose-response 
relationships for the wild type homomeric α1, α2 and α3 GlyRs and the wild type heteromeric α1β and 
α3β GlyRs. In this and all subsequent figures showing dose-response curves, the continuous lines 
represent fits of the Hill equation to the averaged dose-response relations. The averaged EC50 and nH 
values, determined by averaging the parameters determined from curve fits to individual dose-responses, 
are shown in Table 1. The EC50 values are similar to those measured previously at these receptors 
(Handford et al. 1996; Shan et al. 2001; Miller et al. 2004), except for those of the α3 and α3β GlyRs 
which are several fold higher than previously reported (Meier et al. 2005; Miller et al. 2005). The reasons 
for this are unknown. The averaged glycine dose-response relationships for GlyRs incorporating 
mutations to the 2’ pore-lining position (i.e., α1G2’P, α1G2’A, α1G2’S and α1βP2’G) and the 6’ pore-lining 
position (i.e., α1T6’S, α1T6’F, α1T6’A and α1T6’V) are shown in Fig. 2C and D, respectively. Averaged 
parameters of best fit to all dose-response curves are shown in Table 1.  
 
PTXININ and PTN sensitivity of GlyRs mutated at the 6’ position 
As shown in the M2 domain sequence alignment in Fig. 3, the T6’ residue is highly conserved 
among anionic cys-loop receptors (Fig. 3). Indeed, a ring of five T6’ residues has been shown to be 
essential for high affinity PTXININ inhibition (Gurley et al. 1995; Shan et al. 2001, 2002; Sedelnikova et 
al. 2006). Molecular modelling studies on homomeric α1 GlyRs, ρ1 GABAARs and β3 GABAARs 
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predict that T6’ hydroxyl groups form hydrogen bonds with oxygens common to both PTXININ and 
PTN (Zhorov and Bregestovski 2000; Chen et al. 2006). Because the earlier modelling of the interaction 
between PTXININ and the GlyR pore (Zhorov and Bregestovski 2000) was performed prior to the 
determination of the nAChR pore structure at 4 Å resolution (Miyazawa et al. 2003; Unwin 2005), we 
have re-investigated this interaction using a model homomeric α1 GlyR pore based on this new structural 
template. The model was generated as described above and computational docking was used to assess 
feasible binding sites for PTXININ and PTN within the pore lumen. The vast majority of the docked 
conformations for PTXININ were in contact with T6’ residues, including a major cluster within 1.5 Å 
rmsd comprising 40% of the total. For all docks within this cluster, there were two or three hydrogen 
bonds between T6’ residues and the exocyclic oxygens common to PTXININ and PTN, whereas the 
isopropenyl group of PTXININ, the point of variation with PTN, was in closer proximity to the G2’ 
residues (Fig. 3B, left). Both of these features are consistent with PTXININ docking in the β3 GABAAR 
homomer (Chen et al. 2006) and broadly consistent with the earlier GlyR study (Zhorov and 
Bregestovski 2000). Computational docking of PTN within our model GlyR pore showed a greater 
variety of conformations, apparently due to the additional hydrogen bonding capacity of its unique 
dimethyl-methanol group. Nevertheless, a significant cluster overlapped closely with the major 
PTXININ cluster, with similar hydrogen bonds and the dimethyl-methanol group positioned close to the 
G2’ residues (Fig. 3B, right). 
If this model is correct, then 6’ mutations should equally affect GlyR sensitivity to PTXININ and 
PTN. To test this hypothesis, we compared the IC50 values of PTXININ and PTN at the α1T6’F, α1T6’S, 
α1T6’A and α1T6’V GlyRs. The T6’F mutation (the α to β subunit substitution) was tested as it is known to 
cause a significant reduction in PTX sensitivity but does not abolish it completely (Shan et al. 2001; 
Sedelnikova et al. 2006). We also tested the T6’A and T6’S mutations, which are more conservative 
substitutions for threonine residues. The T6’A substitution removes the hydroxyl group (thereby the 
hydrogen bond donor) of the threonine side chain, whereas the T6’S mutation specifically eliminates the 
methyl group. Finally, we investigated the T6’V mutation. This replaces the threonine hydroxyl group 
with a non-polar methyl group.  
In all experiments, the PTXININ and PTN inhibitory dose-response relationships were measured 
at the glycine EC50 value as listed in Table 2. Examples of the effects of increasing concentrations of 
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PTXININ and PTN on α1 GlyR currents, together with averaged inhibitory dose-response relationships, 
are shown in Fig. 4A. The averaged parameters of best fit summarised in Table 2. This result confirms 
the previous finding (Lynch et al. 1995) that α1 GlyRs are equally sensitive to both compounds. The 
corresponding results for the α1T6’F GlyR, shown in Fig. 4B, reveal a significantly decreased receptor 
sensitivity to both PTXININ and PTN, although the α1T6’F GlyR remained equally sensitive to both 
compounds. Although full dose-responses could not be generated due to its low sensitivity to both 
compounds, we found that 100 µM PTXININ and PTN reduced α1T6’F GlyR current by 30 ± 5 % and 35 
± 7 % (n = 5 for each), respectively. The T6’A, T6’S and T6’V mutations completely eliminated GlyR 
sensitivity to both PTXININ and PTN (Fig. 4B, Table 2). As all three mutations are conservative 
substitutions, their effects on PTXININ and PTN sensitivity are presumably reasonably specific in 
disrupting the hydrogen bonding and hydrophobic interaction capabilities of T6’ side chains. The finding 
that the T6’V and T6’S mutations both eliminated sensitivity to PTXININ and PTN implies that both 
hydrogen bonds and hydrophobic interactions are important determinants of their sensitivity. The 
predicted roles of T6’ side chains in coordinating PTXININ and PTN are considered further in the 
Discussion. Overall, the results so far provide strong evidence that the GlyR T6’ side chains coordinate 
PTXININ and PTN via molecular groups common to both molecules. 
 
PTXININ and PTN sensitivity of GlyRs mutated at the 2’ position 
Despite their similar structures, PTXININ is much more potent than PTN at inhibiting 
GABAARs in vivo (Jarboe et al. 1968). Consistent with earlier studies of GlyRs and GABAARs (Zhorov 
and Bregestovski 2000; Chen et al. 2006), our modelling studies predict that the non-conserved groups of 
PTXININ and PTN come into close contact with the GlyR 2’ residues (Fig. 3B). GABAARs usually have 
alanines, valines or serines at the 2’ position, which are all larger than the 2’ glycine of the α1GlyR (Fig. 
3). One modelling study predicted that the 2’ alanine methyl group of homomeric β3 GABAARs forms 
hydrophobic interactions with the isopropenyl group of PTXININ (Chen et al. 2006). Such interactions 
are likely to be less favourable with the more hydrophilic dimethyl-methanol group of PTN. The small 2’ 
glycine of the α1GlyR would eliminate such interactions, but may permit backbone groups to contribute 
to hydrogen bonds or hydrophobic interactions in a manner that permits energetically equivalent 
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interactions with both blockers (Zhorov and Bregestovski 2000). An alternate or additional possibility is 
that the small glycine side chain enables both molecules to sterically fit equally well at this level of the 
pore. Based on all these considerations, we hypothesised that the G2’A substitution in the α1 GlyR 
should result in an increased sensitivity to PTXININ and a decreased sensitivity to PTN. 
The amino acid sequences of α1 and α2 GlyR M2 domains are identical with the exception of a 
G2’A substitution in the α2 subunit (Fig. 3). As shown in Fig. 5A, the α2 GlyR indeed exhibited a 
remarkably increased sensitivity to PTXININ and a modestly reduced sensitivity to PTN (Table 2). As 
expected, the PTXININ and PTN sensitivities of the α1G2’A GlyR were similar to those of the α2 GlyR 
(Fig. 5B, Table 2). Thus, the differential sensitivity of the α1 and α2 GlyRs is due to the amino acid 
difference at the 2’ position. This confirms the model predictions that the 2’ residue is important for 
distinguishing between these 2 molecules. 
In an attempt to discern the molecular basis by which this discrimination occurs, we investigated 
the PTXININ and PTN sensitivities of the α1G2’S GlyR. Serine is larger and more hydrophilic than 
alanine. If side chain volume dominates the process by which the α1G2’A GlyR distinguishes PTXININ 
from PTN, then the α1G2’S GlyR should be more sensitive to PTXININ than PTN. If side chain polarity 
dominates the selectivity process, however, then the α1G2’S GlyR should be more sensitive to the more 
polar PTN than to PTXININ. As shown in Fig. 5C and summarised in Table 2, PTXININ remains much 
more potent than PTN as an inhibitor of the α1G2’S GlyR. This suggests that the space available at the 2’ 
region is more important than 2’ binding interactions in discriminating between PTXININ and PTN. 
However, the increased PTXININ sensitivity of the α1G2’A GlyR relative to the α1 GlyR implies that 
hydrophobic interactions improve the binding of PTXININ to receptors containing 2’ alanines. 
 
Role of the β subunit 
The GlyR β subunit shares an unusually low amino acid homology with the M2 domains of all 
other anionic cys-loop receptor subunits (Fig. 3). Of particular relevance to the present study, this subunit 
contains non-conserved proline and phenylalanine groups at the 2’ and 6’ positions, respectively. 
Heteromeric αβ GlyRs are believed to exist in a 2α:3β stoichiometry (Grudzinska et al. 2005), implying 
the existence of prolines at three of the five 2’ positions. Given the large size of the 2’ proline relative to 
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glycine and the conclusion above that steric volume at least partly mediates α2 GlyR discrimination 
between PTXININ and PTN, it might be expected that the α1β GlyR should be more sensitive to 
PTXININ than PTN. We found, however, that the α1β GlyR was equally sensitive to both compounds 
(Fig. 6A, Table 2) in contrast to the homomeric α1G2’P GlyR, which was one hundred-fold more sensitive 
to PTXININ than PTN (Fig. 6A, Table 2). One possible explanation is that in α1β GlyRs, the α1 G2’ 
residues create sufficient space for PTN binding despite the prolines at the 2’ position in the β subunit. 
Alternatively, the other differences in the β subunit may have broader effects on the overall structure of 
the pore, increasing the space available at the 2’ position. To differentiate between these alternatives, we 
investigated the PTXININ and PTN sensitivities of the α1βP2’G GlyR, which restores the ring of 2’ 
glycines, but incorporates the β subunit. As shown in Fig. 6C, the α1βP2’G GlyR exhibits a drastically 
decreased sensitivity to PTN relative to PTXININ, the reverse of what occurs in homomeric α1 GlyRs 
when a ring of 2’ glycines is present. These results imply that the β subunit as a whole imposes a 
structural change that alters the structure of the 2’ – 6’ binding site. Consequently, we conclude that the 
determinants of PTXININ and PTN binding to the α1 homomeric GlyR do not apply directly to the 
α1β GlyR. Investigation of the heteromeric receptor discriminatory mechanism will be complicated by 
the low sequence homology between the β and α1 subunits (Fig. 3A) and the difficulty in ascertaining 
the functional expression of β subunits with increased sensitivities to PTXININ and PTN. 
 
PTXININ and PTN as GlyR subunit-specific pharmacological probes 
Glycinergic synapses on neurons in spinal cord dorsal horn nociceptive pathways comprise either 
α1β or α3β GlyRs or a mixture of both (Harvey et al. 2004; Zeilhofer et al. 2005). It is not yet possible 
to define the respective roles of these receptors in pain signalling because few, if any, compounds are 
known to selectively discriminate between α1- and α3-containing GlyRs (Webb and Lynch 2007). As 
α3 GlyR subunits contain an alanine at the 2’ position (Fig. 3), we hypothesised that α3β GlyRs may be 
pharmacologically differentiated from α1β GlyRs by a differential sensitivity to PTXININ and PTN. 
Accordingly, we measured the PTXININ and PTN inhibitory dose-responses at the homomeric α3 GlyR 
and the heteromeric α3β GlyR. The results, summarised in Fig. 7 and Table 2, confirm that α3 and 
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α3β GlyRs are both more sensitive to PTXININ than to PTN. In Fig. 7A and B, the corresponding 
PTXININ and PTN dose-response curves for the α1 and α1β GlyRs, respectively, are included as dashed 
lines for comparison. The α1β and α3β GlyRs share a similar sensitivity to PTN, although α3β GlyRs 
are significantly more sensitive than α1β GlyRs to PTXININ.  
Table 2 also shows that the α3 homomeric GlyR is much more sensitive than the α3β 
heteromeric GlyR to PTXININ. This compound thus provides a better tool than PTX or PTN for 
discriminating between these two isoforms in heterologous expression systems. 
 
Discussion 
 
Structural basis of PTXININ and PTN binding in the homomeric α1 GlyR pore 
Mutations can affect antagonist IC50 values either by directly modifying ligand binding sites or 
by non-specific structural disruptions. Comparing the effects of two blockers with closely related 
structures can help to discriminate between these possibilities. The reasoning for this is that non-specific 
structural disruptions should have similar effects on the binding of two molecules with closely related 
structures provided that they interact with the receptor through multiple similar binding interactions. 
Thus, the fact that 2’ mutations had differential effects on GlyR sensitivity to PTXININ and PTN 
suggests direct interactions between residues at the 2’ pore-lining position and the non-conserved 
molecular groups on these molecules. 
Threonine residues can contribute to both hydrogen bonds (via their hydroxyl groups) and to 
hydrophobic interactions (via their methyl groups). Selective elimination of the 6’ threonine hydrophobic 
interacting capability via the structurally-conservative T6’S mutation, of their hydrogen bonding 
capability by the T6’V mutation, and of both by the T6’A mutation, completely eliminated sensitivity to 
both PTXININ and PTN in homomeric α1 GlyRs. These results imply that both hydrophobic interactions 
and hydrogen bonds contributed by 6’ threonine residues are important for coordinating PTXININ and 
PTN. The α1 subunit T6’F mutation strongly reduced receptor sensitivity to both compounds but did not 
eliminate it (Fig. 4B). As this substitution also eliminates the hydrogen bonding capacity of the 6’ side 
chain, it might be expected that it should also eliminate the ability of both compounds to bind in the pore. 
   
 12
The fact that it does not implies that the larger phenylalanine side chain imposes a non-specific structural 
disruption that partially compensates for the loss in affinity caused by elimination of the hydrophobic 
interaction capability. Nevertheless, the T6’F result is significant as it is an example of a 6’ mutation that 
equally affects receptor sensitivity to PTXININ and PTN. Together, these results allow us to conclude 
that 6’ threonines coordinate PTXININ and PTN via molecular groups common to both molecules. 
Molecular modelling reveals the three common exocyclic oxygens to be the most likely hydrogen bond 
receivers. 
As mutations to 2’ residues have differential effects on receptor sensitivity to PTXININ and 
PTN, we conclude that the non-conserved regions of PTXININ and PTN are located directly adjacent to 
this part of the pore. It is worth reconsidering the structural differences between the molecules. PTN is 
larger than PTXININ by the size of a water molecule. The PTN dimethyl-methanol group can contribute 
to hydrophobic interactions via its two methyl groups and to hydrogen bonds via its hydroxyl group, 
whereas the PTXININ isopropenyl group is capable of forming only hydrophobic interactions. The two 
molecules can thus be discriminated on the basis of size, chemical bonding properties, or both. 
The homomeric α1 GlyR contains a ring of small 2’ glycine residues which expose both polar 
and non-polar backbone groups to the pore lumen. The G2’S substitution, which adds a hydrogen bond 
donor to the side chain, had no effect on sensitivity to PTXININ but drastically reduced sensitivity to 
PTN. This result strongly suggests that PTN is excluded on the basis of its larger size. The G2’A 
substitution, which also reduces the pore exposure of backbone groups and adds a moderately 
hydrophobic methyl group to the side chain, significantly increases receptor sensitivity to PTXININ but 
modestly reduces sensitivity to PTN. This result is also consistent with a size exclusion mechanism but 
suggests that PTXININ may have enhanced binding to this residue via a hydrophobic interaction. 
 
PTXININ and PTN binding in the heteromeric α1β GlyR pore 
Incorporation of the β subunit is known to produce a dramatic (> 20-fold) reduction in PTX 
sensitivity (Pribilla et al. 1992; Lynch et al. 1995). In the present study we found that β subunit co-
expression produced an approximately 5-fold reduction in α1 GlyR sensitivity to both PTXININ and 
PTN (Table 2), suggesting that our experiments may have been performed on a mixture of α1 
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homomeric and α1β heteromeric receptors (Burzomato et al. 2003). However, this uncertainty does not 
impinge significantly on our ability to interpret the β subunit results because the presumed receptor 
mixture exhibited similar sensitivities to PTXININ and PTN whereas the βP2’G mutation caused a 
significant and selective decrease in PTN sensitivity (Table 2).  
The unusually low M2 domain amino acid sequence homology between GlyR β and α subunits 
implies that heteromeric αβ GlyRs and α homomeric GlyRs have different pore structures.  Thus, the 
above discriminatory mechanism may not necessarily pertain to β subunit-containing GlyRs. Indeed, 
despite containing three bulky prolines at the 2’ position, heteromeric α1β GlyRs are equally sensitive to 
PTXININ and PTN. When these prolines are replaced by glycines, the α1βP2’G GlyRs retain a relatively 
high sensitivity to PTXININ but sensitivity to PTN is largely lost. This result cannot be reconciled with 
the pattern observed with α1 homomeric GlyRs and indicates that the α1β GlyR pore discriminates 
between PTXININ and PTN via a different mechanism to homomeric α GlyRs. Note that the generally 
lower PTX sensitivity of α1β heteromeric GlyRs is due to a reduction in the number of 6’ threonines, as 
substitution of β subunit 6’ phenylalanines by threonines restores PTX sensitivity (Shan et al. 2001).  
 
PTXININ and PTN as pharmacological probes 
Inhibition of α3β GlyRs by the inflammatory mediator, prostaglandin E2, in spinal cord lamina I 
neurons results in the disinhibition of firing in nociceptive projection neurons (Ahmadi et al. 2002; 
Harvey et al. 2004). This mechanism may underlie inflammation-induced hyperalgesia or allodynia 
(Zeilhofer 2005; Lynch and Callister 2006), and substances that can restore glycinergic 
neurotransmission in these neurons may have potential as therapeutic lead compounds for chronic 
inflammatory pain. The α3β and α1β GlyRs are equally represented at lamina I neuronal synapses 
(Harvey et al. 2004).  Although both receptor subtypes are potential therapeutic targets, their relative 
contributions to the net glycinergic synaptic current magnitude are as yet unknown. It is also not known 
why the α3 subunit is highly expressed in these neurons, but is sparsely distributed throughout the rest of 
the spinal cord (Harvey et al. 2004). Resolving these questions may provide useful insights into spinal 
cord pain processing mechanisms. We have shown that the α1β GlyR is equally sensitive to PTXININ 
and PTN, whereas the α3β GlyR has a three-fold increased sensitivity to PTXININ over PTN. Thus, a 
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comparison of the inhibitory effects of PTN and PTXININ may be useful for estimating the relative 
contributions of α1β and α3β GlyRs to the net glycinergic synaptic current.  
 
Conclusion 
Our results suggest that PTXININ and PTN bind to T6’ residues by hydrogen bonding with the 
three exocyclic double-bonded oxygens common to both molecules. When PTXININ and PTN are 
coordinated in this position, their variable groups align with the 2’ level (Fig. 3B). We propose that there 
is minimal chemical bonding with pore-lining groups near the 2’ level and that both compounds have 
equivalent affinities at the homomeric α1 GlyR because the 2’ glycine side chain affords sufficient space 
to accommodate both molecules equally well. However, homomeric α2 and α3 GlyRs and most 
GABAAR subunits contain larger residues at the 2’ position. We propose that these reduce space 
available at the 2’ level, which sterically prevents the larger PTN molecule from adopting its optimal 
binding position in the pore. The binding of the PTXININ may also be improved by a hydrophobic 
interaction between the 2’ alanine and its unique isoproprenyl group. Thus, homomeric GlyRs, and 
probably also GABAARs, discriminate between PTXININ and PTN primarily on the basis of size. In 
contrast, heteromeric α1β GlyRs are equally sensitive to PTXININ and PTN despite containing three 
bulky proline residues at the 2’ position. This suggests that the above discriminatory mechanism may not 
apply to β subunit-containing GlyRs. As α3β GlyRs exhibit a differential sensitivity to PTXININ and 
PTN whereas α1β GlyRs do not, a comparative analysis of the effect of both compounds may be useful 
for estimating the relative contributions of α3β and α1β GlyRs to glycinergic inhibition in spinal 
nociceptive neurons. 
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Figure legends 
 
Figure 1. Diagrammatic, ball and stick and space-filling models of PTXININ and PTN. 
 
Figure 2. Glycine sensitivities of GlyRs employed in this study. A. Examples of currents activated by the 
indicated glycine concentrations in cells expressing the indicated GlyR subunits. In this and all 
subsequent figures, inward currents are represented as downward deflections and glycine was applied for 
the period represented by the unfilled bar. The horizontal 5 s scale bar applies to all traces displayed in 
this figure. B, C, D. These panels display the averaged dose-responses for the indicated wild type and 
mutant GlyRs. Mean parameters of best fit to all dose-response relationships are given in Table 1.     
 
Figure 3. Proposed molecular determinants of PTXININ and PTN binding in the pore of anionic cys-
loop receptors. A. Amino acid sequence alignment of M2 domains of the indicated human GlyR and 
GABAAR subunits. Residues at the 2’ and 6’ positions are highlighted. B. Pentameric model of the M2 
region of the homomeric α1 GlyR, viewed from the plane of the membrane with the extracellular side at 
the top, showing the best docking conformation  for PTXININ (left panel), including hydrogen bonds 
with T6’ residues, and a similar docking conformation for PTN (right panel). Both blocking molecules 
are represented as all atom structures. The M2 domain backbones are shown as ribbons with the front 
domain removed for clarity. The pore-lining G2’ α-carbons are shown as white spheres and the T6’, L9’ 
and T10’ residues are shown as sticks, coloured by atom. 
 
Figure 4. Effects of 6’ mutations on α1 GlyR sensitivity to PTXININ and PTN. A. Examples of current 
inhibition induced by indicated concentrations of PTXININ and PTN in a cell expressing wild type α1 
GlyRs, together with averaged inhibitory dose-responses for both compounds. In this and all subsequent 
figures, filled circles represent PTXININ and unfilled circles represent PTN. Table 2 contains the 
parameters of best fit to dose-response curves and the EC50 glycine concentrations used to activate the 
receptors for this and all other GlyRs investigated in this study. B. Examples of the effects of 100 µM 
PTXININ and PTN on α1T6'F, α1T6'S and α1T6'A GlyR currents.  
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Figure 5. Effects of conservative 2’ substitutions on α1 GlyR sensitivity to PTXININ and PTN. Panels 
A, B and C show examples of current inhibition induced by indicated concentrations of PTXININ and 
PTN in cells expressing wild type α2 GlyRs (A), α1G2’A GlyRs (B) and α1G2’S GlyRs (C) together with 
averaged inhibitory dose-responses for both compounds. In panel A, the curve fits to α1 GlyR PTXININ 
and PTN dose-responses are included as dashed lines for comparison. 
 
 Figure 6. Effects of the β subunit on GlyR sensitivity to PTXININ and PTN. Panels A, B and C show 
examples of current inhibition induced by indicated concentrations of PTXININ and PTN in cells 
expressing wild type α1β GlyRs (A), α1G2’P GlyRs (B) and α1βP2’G GlyRs (C) together with averaged 
inhibitory dose-responses for both compounds. 
 
Figure 7. Sensitivity of α3-containing GlyRs to PTXININ and PTN. Panels A and B show examples of 
current inhibition induced by indicated concentrations of PTXININ and PTN in cells expressing wild 
type α3 GlyRs and α3β GlyRs, together with averaged inhibitory dose-responses for both compounds. 
The corresponding PTXININ and PTN inhibitory dose-responses at the α1 and α1β GlyRs are included 
as dashed lines in panels A and B, respectively. 
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Table 1. Glycine sensitivity of GlyRs employed in this study. 
 
GlyR EC50 (µM) nH n 
α1 31 ± 2 2.5 ± 0.4 10 
α2 95 ± 7*** 1.9 ± 0.2 5 
α3 265 ± 3*** 2.6 ± 0.1 3 
α1β 51 ± 9** 1.6 ± 0.2 6 
α3β 219 ± 18*** 2.5 ± 0.5 6 
α1G2’A 33 ± 1 3.5 ± 0.3 4 
α1G2’S 37 ± 4 1.3 ± 0.3 5 
α1G2’P 147 ± 27*** 2.5 ± 0.3 5 
α1T6’S 1.1 ± 0.2*** 1.1 ± 0.3 4 
α1T6’A 6.6 ± 0.7*** 1.0 ± 0.1 4 
α1T6’F 6.4 ± 1.1*** 1.5 ± 0.1 6 
α1T6’V 416 ± 64*** 1.0 ± 0.2 4 
α1βP2’G 61 ± 6*** 2.3 ± 0.5 4 
 
* P<0.05, **P<0.01, ***P<0.001 denote significance relative to the α1 GlyR using a Student’s unpaired 
t-test.  
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Table 2. PTXININ and PTN sensitivities of GlyRs investigated in this study. 
PTXININ PTN  
GlyR 
[Glycine] # 
(µM) IC50 (µM) nH n IC50 (µM) nH n 
α1 30 5.1 ± 0.6 0.98 ± 0.05 8 5.2 ± 0.7 1.09 ± 0.07 6 
α2 100 0.41 ± 0.06** 0.71 ± 0.07 3 13.1 ± 0.4*** 0.90 ± 0.17 4 
α3 220 0.43 ± 0.06** 0.76 ± 0.07 4 6.0 ± 0.9 0.88 ± 0.20 3 
α1β 40 27 ± 1*** 1.2 ± 0.1 4 27 ± 2*** 1.26 ± 0.09 5 
α3β 220 8.9 ± 1.1** 1.1 ± 0.1 4 24 ± 1*** 0.94 ± 0.07 4 
α1G2’A 30 0.41 ± 0.06*** 1.00 ± 0.07 7 9.2 ± 1.2* 0.98 ± 0.09 8 
α1G2’S 40 4.8 ± 0.4 1.4 ± 0.6 5 106 ± 7*** 1.7 ± 0.2 6 
α1G2’P 90 0.98 ± 0.16*** 0.73 ± 0.09 5 97 ± 8*** 0.89 ± 0.07 5 
α1T6’S 1 >200  4 >200  4 
α1T6’A 6 >200  4 >200  4 
α1T6’F 8 >100  5 >100  5 
α1T6’V 400 >200  4 >200  4 
α1βP2’G 60 24 ± 8** 0.9 ± 0.2 3 149 ± 5*** 0.70 ± 0.13 4 
 
# [Glycine] refers to the EC50 glycine concentration used to activate GlyRs in order to measure PTXININ 
and PTN inhibitory dose-responses. 
* P<0.05, **P<0.01, ***P<0.001 denote significance relative to the α1 GlyR using a Student’s unpaired 
t-test.  
 
 
 
 







